EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
+24.65%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$262M
AUM Growth
+$262M
Cap. Flow
+$10.6M
Cap. Flow %
4.04%
Top 10 Hldgs %
75.81%
Holding
46
New
12
Increased
5
Reduced
5
Closed
13

Top Buys

1
ARDX icon
Ardelyx
ARDX
$17M
2
FPRX
Five Prime Therapeutics, Inc.
FPRX
$15M
3
AGIO icon
Agios Pharmaceuticals
AGIO
$10.6M
4
KA
Kineta, Inc. Common Stock
KA
$9.39M
5
DERM
Dermira, Inc.
DERM
$8.45M

Top Sells

1
TVTX icon
Travere Therapeutics
TVTX
$21.8M
2
XLRN
Acceleron Pharma Inc.
XLRN
$12.6M
3
CYTK icon
Cytokinetics
CYTK
$11.9M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
$9.51M
5
EPZM
Epizyme, Inc
EPZM
$7.73M

Sector Composition

1 Healthcare 85.46%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IMGN
26
DELISTED
Immunogen Inc
IMGN
– –
0
– –
EPZM
27
DELISTED
Epizyme, Inc
EPZM
– –
-755,046
Closed -$7.73M
ADXS
28
DELISTED
Advaxis, Inc.
ADXS
– –
-92,800
Closed -$751K
AKTX
29
Akari Therapeutics
AKTX
$21.4M
– –
-63,468
Closed -$856K
BMY icon
30
Bristol-Myers Squibb
BMY
$96.7B
– –
0
– –
COLL icon
31
Collegium Pharmaceutical
COLL
$1.25B
– –
-281,776
Closed -$3.34M
EDIT icon
32
Editas Medicine
EDIT
$225M
– –
-85,469
Closed -$2.09M
ENTA icon
33
Enanta Pharmaceuticals
ENTA
$189M
– –
-136,882
Closed -$3.02M
EXAS icon
34
Exact Sciences
EXAS
$9.33B
– –
0
– –
GILD icon
35
Gilead Sciences
GILD
$140B
– –
0
– –
TVTX icon
36
Travere Therapeutics
TVTX
$1.75B
– –
-1,225,084
Closed -$21.8M
XNCR icon
37
Xencor
XNCR
$594M
– –
-168,000
Closed -$3.19M
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-244,950
Closed -$9.51M
XLRN
39
DELISTED
Acceleron Pharma Inc.
XLRN
– –
-371,381
Closed -$12.6M
AGN
40
DELISTED
Allergan plc
AGN
– –
0
– –
FWP
41
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
– –
-84,332
Closed -$1.53M
ARRY
42
DELISTED
Array Biopharma Inc
ARRY
– –
0
– –
TSRO
43
DELISTED
TESARO, Inc.
TSRO
– –
-9,200
Closed -$773K
CASC
44
DELISTED
Cascadian Therapeutics, Inc.
CASC
– –
0
– –
1
2